{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:53:22Z","timestamp":1789826002119,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico \u2013 Brasil (CNPq)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e a Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe (Fapitec\/SE) - Brasil","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil (CAPES","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos - Brasil (FINEP)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.fct.2019.01.038","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T23:40:23Z","timestamp":1549755623000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Development of morin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects"],"prefix":"10.1016","volume":"126","author":[{"given":"Bruno dos Santos","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio de Alc\u00e2ntara","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Clara Ramos","family":"da Silva Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vict\u00f3ria Caroline Nunes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela das Gra\u00e7as Gomes","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-8426","authenticated-orcid":false,"given":"Saravanan","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-4751","authenticated-orcid":false,"given":"Erik Willyame Menezes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Neves","family":"Marreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Cavalcante","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson Roberto Guedes da Silva","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-8982","authenticated-orcid":false,"given":"Jullyana de Souza Siqueira","family":"Quintans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-938X","authenticated-orcid":false,"suffix":"Jr.","given":"Lucindo Jos\u00e9","family":"Quintans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Antunes de Souza","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2019.01.038_bib1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.foodchem.2015.10.023","article-title":"Characterization of beta-cyclodextrin inclusion complexes containing an essential oil component","volume":"196","author":"Abarca","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.fct.2019.01.038_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4314\/ajtcam.v11i3.3","article-title":"Morin, a flavonoid, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats","volume":"11","author":"Al-Numair","year":"2014","journal-title":"Afr. J. Tradit., Complementary. Altern. Med. (AJTCAM)"},{"key":"10.1016\/j.fct.2019.01.038_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/bip.20147","article-title":"Host-guest complexation of oxicam NSAIDs with\u202f?-cyclodextrin","volume":"75","author":"Banerjee","year":"2004","journal-title":"Biopolymers"},{"key":"10.1016\/j.fct.2019.01.038_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2004.04.007","article-title":"NMR studies of the inclusion complex between \u03b2-cyclodextrin and paroxetine","volume":"22","author":"Bernini","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.fct.2019.01.038_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopha.2017.06.091","article-title":"Inclusion complex between \u03b2-cyclodextrin and hecogenin acetate produces superior analgesic effect in animal models for orofacial pain","volume":"93","author":"Carvalho","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fct.2019.01.038_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00004770-200303000-00009","article-title":"Proinflammatory cytokines induce cyclooxygenase-2 mRNA and protein expression in human pulp cell cultures","volume":"29","author":"Chang","year":"2003","journal-title":"J. Endod."},{"key":"10.1016\/j.fct.2019.01.038_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2015.07.060","article-title":"Serum and tissue pharmacokinetics of silibinin after per os and i.v. administration to mice as a HP-\u03b2-CD lyophilized product","volume":"493","author":"Christodoulou","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.fct.2019.01.038_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0100-879X2004000300018","article-title":"An electronic pressure-meter nociception paw test for mice","volume":"37","author":"Cunha","year":"2004","journal-title":"Braz. J. Med. Biol. Res. = Rev. Bras. Pesqui. Med. Biol."},{"key":"10.1016\/j.fct.2019.01.038_bib9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.0409225102","article-title":"A cascade of cytokines mediates mechanical inflammatory hypernociception in mice","volume":"102","author":"Cunha","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fct.2019.01.038_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","article-title":"Cyclodextrins and their uses: a review","volume":"39","author":"Del Valle","year":"2004","journal-title":"Process Biochem."},{"key":"10.1016\/j.fct.2019.01.038_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.lfs.2003.07.017","article-title":"Morin sulfates\/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock","volume":"74","author":"Fang","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2019.01.038_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.foodchem.2018.02.007","article-title":"Microencapsulation of caffeic acid phenethyl ester and caffeic acid phenethyl amide by inclusion in hydroxypropyl-\u03b2-cyclodextrin","volume":"254","author":"Garrido","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.fct.2019.01.038_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD): A toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2019.01.038_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.etap.2014.01.026","article-title":"Therapeutic potential of morin against liver fibrosis in rats: Modulation of oxidative stress, cytokine production and nuclear factor kappa B","volume":"37","author":"Heeba","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2019.01.038_bib15","series-title":"Phase-solubility techniques. Advances in Analytical Chemistry Instrumentation","author":"Higuchi","year":"1965"},{"key":"10.1016\/j.fct.2019.01.038_bib16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.carbpol.2012.07.057","article-title":"Investigation of inclusion complex of cilnidipine with hydroxypropyl-\u03b2-cyclodextrin","volume":"90","author":"Hu","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.fct.2019.01.038_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ijpharm.2016.08.007","article-title":"Preparation of inclusion complex of apigenin-hydroxypropyl-\u03b2-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement","volume":"511","author":"Huang","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.fct.2019.01.038_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: structure, physicochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.fct.2019.01.038_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.saa.2007.12.020","article-title":"Complexation of morin with three kinds of cyclodextrin: A thermodynamic and reactivity study","volume":"71","author":"Jullian","year":"2008","journal-title":"Spectrochim. Acta A."},{"key":"10.1016\/j.fct.2019.01.038_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.biopha.2016.10.001","article-title":"Anticancer effects of morin-7-sulphate sodium, a flavonoid derivative, in mouse melanoma cells","volume":"84","author":"Li","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fct.2019.01.038_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jphp.12708","article-title":"The formation of a host-guest inclusion complex system between \u03b2-cyclodextrin and baicalin and its dissolution characteristics","volume":"69","author":"Li","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.fct.2019.01.038_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.foodchem.2012.02.207","article-title":"Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins","volume":"134","author":"Liu","year":"2012","journal-title":"Food Chem."},{"key":"10.1016\/j.fct.2019.01.038_bib23","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.foodchem.2013.03.097","article-title":"Physicochemical characterisation of the supramolecular structure of luteolin\/cyclodextrin inclusion complex","volume":"141","author":"Liu","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.fct.2019.01.038_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.foodres.2013.08.007","article-title":"Preparation and physicochemical characterization of the supramolecular inclusion complex of naringin dihydrochalcone and hydroxypropyl-\u03b2-cyclodextrin","volume":"54","author":"Liu","year":"2013","journal-title":"Food Res. Int."},{"key":"10.1016\/j.fct.2019.01.038_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.fct.2019.01.038_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.physbeh.2007.06.015","article-title":"Behavioural, histological and cytokine responses during hyperalgesia induced by carrageenan injection in the rat tail","volume":"92","author":"Loram","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.fct.2019.01.038_bib27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ni1275","article-title":"Immune cell migration in inflammation: present and future therapeutic targets","volume":"6","author":"Luster","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.fct.2019.01.038_bib28","first-page":"117","article-title":"Ferramentas anal\u00edticas aplicadas \u00e0 caracteriza\u00e7\u00e3o de complexos de inclus\u00e3o f\u00e1rmaco-cyclodextrin","volume":"31","author":"Lyra","year":"2010","journal-title":"Rev. Ci\u00eancias Farm. B\u00e1sica e Apl."},{"key":"10.1016\/j.fct.2019.01.038_bib29","first-page":"559","article-title":"The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability","volume":"7","author":"Ma","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.fct.2019.01.038_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(83)90261-3","article-title":"Effects of several anti-inflammatory drugs on the various parameters involved in the inflammatory response in rat carrageenin-induced pleurisy","volume":"95","author":"Mikami","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2019.01.038_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpba.2014.02.022","article-title":"Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: A review","volume":"101","author":"Mura","year":"2014","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.fct.2019.01.038_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2015.01.058","article-title":"Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review","volume":"113","author":"Mura","year":"2015","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.fct.2019.01.038_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cbi.2013.10.006","article-title":"Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents","volume":"206","author":"Naso","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fct.2019.01.038_bib34","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/ijms13021598","article-title":"Antinociceptive and anti-inflammatory effects of octacosanol from the leaves of Sabicea grisea var. grisea in Mice","volume":"13","author":"Oliveira","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2019.01.038_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/acph-2017-0005","article-title":"A superior preparation method for daidzein-hydroxypropyl-\u03b2-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process","volume":"67","author":"Pan","year":"2017","journal-title":"Acta Pharm."},{"key":"10.1016\/j.fct.2019.01.038_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2016.08.033","article-title":"Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia","volume":"13","author":"Penalva","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.fct.2019.01.038_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jff.2017.06.052","article-title":"Systematic investigation and molecular modelling of complexation between several groups of flavonoids and HP-\u03b2-cyclodextrins","volume":"36","author":"P\u00e9rez-Abril","year":"2017","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.fct.2019.01.038_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.carbpol.2013.09.035","article-title":"Inclusion complex of barbigerone with hydroxypropyl-\u03b2-cyclodextrin: Preparation and in vitro evaluation","volume":"101","author":"Qiu","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.fct.2019.01.038_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.biopha.2018.02.035","article-title":"Molecular chemoprevention by morin \u2013 A plant flavonoid that targets nuclear factor kappa B in experimental colon cancer","volume":"100","author":"Sharma","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fct.2019.01.038_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/IJN.S27641","article-title":"The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability","volume":"7","author":"Shen","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.fct.2019.01.038_bib41","series-title":"Cyclodextrin Drug Carrier Systems","author":"Uekama","year":"1998"},{"key":"10.1016\/j.fct.2019.01.038_bib42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.etap.2013.11.017","article-title":"Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and \u03b2-cell function in streptozotocin-induced diabetic rats","volume":"37","author":"Vanitha","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2019.01.038_bib43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3181\/00379727-143-37397","article-title":"Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat","volume":"143","author":"Vinegar","year":"1973","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.fct.2019.01.038_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molliq.2017.03.098","article-title":"Molecular model and in vitro antioxidant activity of a water-soluble and stable phloretin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex","volume":"236","author":"Wei","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.fct.2019.01.038_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.carbpol.2016.11.093","article-title":"Characterization of glabridin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity","volume":"159","author":"Wei","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.fct.2019.01.038_bib46","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/03639045.2017.1318900","article-title":"Solubility and dissolution rate improvement of the inclusion complex of apigenin with 2-hydroxypropyl-\u03b2-cyclodextrin prepared using the liquid antisolvent precipitation and solvent removal combination methods","volume":"43","author":"Wu","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.fct.2019.01.038_bib47","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.msec.2015.10.037","article-title":"Host\u2013guest system of hesperetin and \u03b2-cyclodextrin or its derivatives: Preparation, characterization, inclusion mode, solubilization and stability","volume":"59","author":"Yang","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.fct.2019.01.038_bib48","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.msec.2017.03.197","article-title":"Supramolecular system of podophyllotoxin and hydroxypropyl-\u03b2-cyclodextrin: Characterization, inclusion mode, docking calculation, solubilization, stability and cytotoxic activity","volume":"76","author":"Yang","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.fct.2019.01.038_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.carbpol.2014.04.006","article-title":"Development of a myricetin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex: Preparation, characterization, and evaluation","volume":"110","author":"Yao","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.fct.2019.01.038_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.carbpol.2010.09.007","article-title":"Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-\u03b2-cyclodextrin","volume":"83","author":"Zeng","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.fct.2019.01.038_bib51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.fct.2017.07.002","article-title":"Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells","volume":"112","author":"Zhang","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2019.01.038_bib52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.carbpol.2013.02.038","article-title":"Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins","volume":"95","author":"Zhou","year":"2013","journal-title":"Carbohydr. Polym."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691519300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691519300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:46:27Z","timestamp":1759527987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691519300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":52,"alternative-id":["S0278691519300493"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2019.01.038","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of morin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2019.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}